SCHEMBL349478

SCHEMBL349478

CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OP(=O)(O)O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP46A1 Q9Y6A2 2/20 0.75
POLA1 P09884 1/20 0.74
OSBP P22059 4/20 0.71
RORC P51449 3/20 0.71
USP2 O75604 2/20 0.71
OSBP2 Q969R2 2/20 0.71
LMNA P02545 1/20 0.71
ABCB1 P08183 1/20 0.71
NR1H3 Q13133 3/20 0.62
GRIN1 Q05586 2/20 0.61
GRIN2A Q12879 2/20 0.61
GBA1 P04062 2/20 0.60
UGCG Q16739 2/20 0.60
GBA2 Q9HCG7 2/20 0.60
NPC1L1 Q9UHC9 4/20 0.59
PLA2G2A P14555 1/20 0.59
CRYAB P02511 1/20 0.58
HMGCR P04035 1/20 0.58
ITGB3 P05106 1/20 0.58
ITGAV P06756 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL593421 1.00 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL28895219 1.00 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL27320611 1.00 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL349479 1.00 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL21879230 0.99 CYP46A1 (0.74) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL15174782 0.99 CYP46A1 (0.74) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL27762145 0.99 CYP46A1 (0.74) CYP46A1POLA1OSBPRORCUSP2
Dimethyl Sulfoxide SCHEMBL9614562 0.96 CYP46A1 (0.70) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL14174362 0.94 CYP46A1 (0.74) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL28419590 0.93 CYP46A1 (0.71) CYP46A1POLA1OSBPRORCUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 780 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326839-A1 TREATMENT OF DISEASES RELATED TO COLONY-STIMULATING FACTOR 1 RECEPTOR DYSFUNCTION USING TREM2 AGONISTS VIGIL NEUROSCIENCE INC (US) 2025-10-23 US claimed
US-20250282866-A1 TREATMENT OF DISEASES RELATED TO ATP-BINDING CASSETTE TRANSPORTER 1 DYSFUNCTION USING TREM2 AGONISTS VIGIL NEUROSCIENCE INC (US) 2025-09-11 US claimed
CN-119654146-A Composition for caring keratin materials and dressing film comprising same 莱雅公司 2025-03-18 CN claimed
CN-119638601-A Guanidine-derived ionizable lipid material, preparation method and application 中国海洋大学 2025-03-18 CN claimed
US-20240261254-A1 DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM CHEERS HEALTH, INC. (US) 2024-08-08 US claimed
CN-117015400-A Treatment of diseases associated with ATP-binding cassette transporter 1 dysfunction using TREM2 agonists 维吉尔神经科学股份有限公司 2023-11-07 CN claimed
CN-116964454-A Treatment of diseases associated with colony stimulating factor 1 receptor dysfunction using TREM2 agonists 维吉尔神经科学股份有限公司 2023-10-27 CN claimed
EP-4255567-A1 TREATMENT OF DISEASES RELATED TO ATP-BINDING CASSETTE TRANSPORTER 1 DYSFUNCTION USING TREM2 AGONISTS Vigil Neuroscience, Inc. (US) 2023-10-11 EP claimed
CN-112641757-B Carrier for transmembrane delivery of molecules and preparation method thereof 中国药科大学 2023-07-28 CN claimed
EP-4192881-A2 TREATMENT OF DISEASES RELATED TO COLONY-STIMULATING FACTOR 1 RECEPTOR DYSFUNCTION USING TREM2 AGONISTS Vigil Neuroscience, Inc. (US) 2023-06-14 EP claimed
WO-1994021230-A1 METHOD AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION CELLEGY PHARMACEUTICALS, INC. (US) 1994-09-29 WO claimed
EP-0582503-A1 Composition formed of an aqueous dispersion of stabilized vesicles of amphiphilic non-ionic lipids L'OREAL (FR) 1994-02-09 EP claimed
US-5277914-A Encapsulation in non-halogenated aprotic solvent THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1994-01-11 US claimed
EP-0544874-A1 METHOD FOR PREPARING SUBMICRON PARTICLES IN THE PRESENCE OF LIPID VESICLES, AND CORRESPONDING COMPOSITIONS L'OREAL (FR) 1993-06-09 EP claimed
WO-1993000068-A1 METHOD FOR PREPARING SUBMICRON PARTICLES IN THE PRESENCE OF LIPID VESICLES, AND CORRESPONDING COMPOSITIONS L'OREAL (FR) 1993-01-07 WO claimed
EP-0467954-A4 PREPARATION OF LIPOSOME AND LIPID COMPLEX COMPOSITIONS 1992-06-03 EP claimed
EP-0467954-A1 PREPARATION OF LIPOSOME AND LIPID COMPLEX COMPOSITIONS. UNIV CALIFORNIA (US) 1992-01-29 EP claimed
US-5077057-A Dissolving in aprotic solvent; extrusion into aqueous solution THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1991-12-31 US claimed
WO-1990011780-A1 PREPARATION OF LIPOSOME AND LIPID COMPLEX COMPOSITIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1990-10-18 WO claimed
WO-1990006775-A1 A NOVEL NONPHOSPHOLIPID LIPOSOME COMPOSITION FOR SUSTAINED RELEASE OF DRUGS LIPOSOME TECHNOLOGY, INC. (US) 1990-06-28 WO claimed